Voters in California Extend Life of Stem Cell Funding Agency
Voters in California Extend Life of Stem Cell Funding Agency
The state will take on additional debt to finance CIRM, which will now continue to fund stem cell research, training, and clinical trials.
Voters in California Extend Life of Stem Cell Funding Agency
Voters in California Extend Life of Stem Cell Funding Agency

The state will take on additional debt to finance CIRM, which will now continue to fund stem cell research, training, and clinical trials.

The state will take on additional debt to finance CIRM, which will now continue to fund stem cell research, training, and clinical trials.

stem cell therapies
California Voters to Decide Future of Stem Cell Funding Agency
California Voters to Decide Future of Stem Cell Funding Agency
Katarina Zimmer | Oct 24, 2020
If approved, Proposition 14 would authorize the state to sell $5.5 billion in bonds to extend the life of CIRM, which funds stem cell research. The ballot measure has its critics.
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
Ruth Williams | Apr 9, 2020
As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.
Activation of the Immune System Underlies Cardiac Cell Therapies
Activation of the Immune System Underlies Cardiac Cell Therapies
Ruth Williams | Nov 27, 2019
A study in mice reveals that stem cell transplants, currently in clinical trials, may not actually require the cells.
Infographic: Light in the Dark
Infographic: Light in the Dark
Nicoletta Lanese | Oct 1, 2019
A new tool helps stem cells integrate with host neural circuitry after implantation in mice.
Stem Cell Funding Agency CIRM Is Nearly Out of Funds
Stem Cell Funding Agency CIRM Is Nearly Out of Funds
Chia-Yi Hou | Jul 8, 2019
The California Institute for Regenerative Medicine has been funding research since it formed in 2004, giving out nearly $3 billion in grants to date.
Clinical Trial Underway for a Natural Killer Cell Therapy
Clinical Trial Underway for a Natural Killer Cell Therapy
Chia-Yi Hou | May 7, 2019
The cells, derived from induced pluripotent stem cells, are in testing as an immunotherapy for cancer patients with solid tumors.
Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Jef Akst | Apr 30, 2019
Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.
Japan Approves iPS Cell Therapy Trial for Spinal Cord Injury
Japan Approves iPS Cell Therapy Trial for Spinal Cord Injury
Catherine Offord | Feb 18, 2019
The treatment will be tested in a handful of patients who suffered nerve damage in sports or traffic accidents.
Call to Stop Using the Term “Mesenchymal Stem Cell”
Call to Stop Using the Term “Mesenchymal Stem Cell”
Abby Olena | Sep 26, 2018
Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.